Probiotiques : ce qui marche, ce qui ne marche pas et comment choisir

The answer depends entirely on which strain, for which condition, and at what dose. This nuance is critical because the probiotic industry often markets generic "probiotic blends" without evidence for the specific combination:

• Strong evidence: Antibiotic-associated diarrhea — a 2017 Cochrane review of 31 RCTs found specific probiotics reduced risk by 42%. Lactobacillus rhamnosus GG and Saccharomyces boulardii have the strongest data.
• Moderate evidence: Irritable bowel syndrome (IBS) — certain strains (Bifidobacterium infantis 35624, Lactobacillus plantarum 299v) show improvement in bloating and abdominal pain in multiple RCTs.
• Moderate evidence: Infectious diarrhea in children — L. rhamnosus GG reduces duration by approximately 1 day.
• Weak/preliminary evidence: Eczema prevention in infants, vaginal health, mental health, weight loss, immune function. Promising signals but inconsistent across studies.

The key principle is strain specificity: Lactobacillus acidophilus NCFM is a completely different organism from Lactobacillus acidophilus La-5, with different clinical evidence. A probiotic label should list the specific strain designation, not just the genus and species.

Navigating the probiotic market requires understanding several key factors:

• Strain identification: The label should specify the complete strain name (e.g., Lactobacillus rhamnosus GG, not just "Lactobacillus blend"). If strains are not identified, the product cannot be matched to clinical evidence.
• CFU count: Colony-forming units indicate the number of live organisms. Most clinically studied doses range from 1-50 billion CFU daily. More is not necessarily better — efficacy depends on the strain, not the count.
• Viability guarantee: Look for "guaranteed through expiration date" rather than "at time of manufacture." Probiotic counts decrease during storage.
• Storage requirements: Some strains require refrigeration, while shelf-stable formulations exist. Check the label and verify storage conditions.
• Third-party testing: ConsumerLab, USP, or NSF certification confirms the product contains what it claims.

Scan your probiotic supplement with WAYJET's Food Package Analyzer to identify the strains, CFU count, and compare them against clinical evidence databases.

Probiotics are generally considered safe for healthy individuals, but several considerations apply:

• Common side effects: Temporary bloating, gas, and mild GI discomfort during the first 1-2 weeks as the gut microbiome adjusts. Starting with a lower dose and gradually increasing can minimize this.
• High-risk populations: Immunocompromised individuals (HIV/AIDS, organ transplant recipients, chemotherapy patients), people with short bowel syndrome, and critically ill patients should avoid probiotics or use them only under medical supervision. Rare cases of probiotic sepsis have been reported in these populations.
• SIBO concern: In people with small intestinal bacterial overgrowth (SIBO), probiotics — particularly Lactobacillus species — may worsen symptoms by adding to the bacterial burden in the small intestine.
• Histamine production: Some probiotic strains produce histamine, which may worsen symptoms in people with histamine intolerance. L. reuteri and L. casei are histamine producers; B. infantis and L. rhamnosus GG are generally better tolerated.

Prebiotics (fiber that feeds beneficial bacteria) may be equally or more important than probiotic supplements for most people. Good prebiotic sources include garlic, onions, asparagus, bananas, oats, and chicory root.